| LXRX Stock | | | USD 0.81 0.05 5.81% |
Lexicon Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Lexicon Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexicon Pharmaceuticals is a good investment. Please check the relationship between Lexicon Pharmaceuticals Other Current Assets and its Cash And Short Term Investments accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Lexicon Stock please use our
How to Invest in Lexicon Pharmaceuticals guide.
Other Current Assets vs Cash And Short Term Investments
Other Current Assets vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexicon Pharmaceuticals Other Current Assets account and
Cash And Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Lexicon Pharmaceuticals' Other Current Assets and Cash And Short Term Investments is 0.47. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Lexicon Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Lexicon Pharmaceuticals' Other Current Assets and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Lexicon Pharmaceuticals are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Current Assets i.e., Lexicon Pharmaceuticals' Other Current Assets and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.47 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Lexicon Pharmaceuticals balance sheet. This account contains Lexicon Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Lexicon Pharmaceuticals fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Lexicon Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexicon Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Lexicon Stock please use our
How to Invest in Lexicon Pharmaceuticals guide.At this time, Lexicon Pharmaceuticals'
Selling General Administrative is fairly stable compared to the past year.
Issuance Of Capital Stock is likely to rise to about 145.7
M in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(2.71) in 2024.
Lexicon Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Lexicon Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexicon Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexicon Stock Analysis
When running Lexicon Pharmaceuticals' price analysis, check to
measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.